Delivery Order SPE2DB20D2014-SPE2DB24FB41U
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of methylergonovine 0.2 mg/ml vials, a medication used to treat postpartum hemorrhage. The contract has a ceiling value of $1,261.51 and runs through March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565735670 - Methylergonovine 0.2 mg/mL vials. The $2,970.20 firm-fixed-price contract has a completion date of September 10, 2024. While this delivery order is not designated as a set-aside, AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a Defense agency. The contract is for the delivery of Methylergonovine 0.2 mg/ml injectable medication, with a fixed-price ceiling value of $4,089.08 and a completion date of July 14, 2025. The contract is not set aside for any particular business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,007.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and an ultimate completion date of February 19, 2025. The contract covers the procurement of 4567304287 units of Methylergonovine 0.2 mg/ml, a medication used to treat certain postpartum conditions. AmerisourceBergen holds a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560843660 - Methylergonovine 0.2 mg/ml vials, with a ceiling value of $1,653.27 and a performance period through May 8, 2023. The contract is a firm fixed-price agreement, with no set-aside designation indicated. Amerisourcebergen is the prime contractor, and there is no...
- This is a $1,525.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4563434905 - METHYLERGONOVINE 0.2 MG TABLET 28S, with a period of performance through January 25, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565749596 - Methylergonovine 0.2 mg/ml vials. The contract is a Delivery Order with a Firm Fixed Price of $2,127.78 and an Ultimate Completion Date of September 11, 2024. The contract is not a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. The contract is part of a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Methylergonovine 0.2 mg tablets (12-pack units) with a ceiling value of $1,334.15. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. This award...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB41UDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of Methylergonovine 0.2 mg/ml medication, with a ceiling value of $1,196.66 and a completion date of March 26, 2024. The contract is a firm fixed price delivery order, which is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/25/24 |